JPMorgan Chase & Co. reiterated their overweight rating on shares of Reckitt Benckiser Group (LON:RB) in a research note issued to investors on Thursday. The brokerage currently has a GBX 7,500 ($101.71) price target on the stock.

Other equities research analysts have also recently issued research reports about the stock. UBS Group set a GBX 7,250 ($98.32) target price on shares of Reckitt Benckiser Group and gave the company a neutral rating in a research report on Wednesday, October 18th. Kepler Capital Markets restated a hold rating and set a GBX 7,300 ($99.00) price target on shares of Reckitt Benckiser Group in a research note on Wednesday, October 18th. Liberum Capital restated a buy rating and set a GBX 8,000 ($108.49) price target on shares of Reckitt Benckiser Group in a research note on Tuesday, December 19th. S&P Global set a GBX 7,500 ($101.71) price target on shares of Reckitt Benckiser Group and gave the company a neutral rating in a research note on Friday, October 20th. Finally, Goldman Sachs Group cut their price target on shares of Reckitt Benckiser Group from GBX 8,130 ($110.25) to GBX 7,920 ($107.40) and set a neutral rating on the stock in a research note on Thursday, September 21st. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have issued a buy rating to the stock. The stock has a consensus rating of Hold and an average price target of GBX 7,614.55 ($103.26).

Reckitt Benckiser Group (RB) traded up GBX 120 ($1.63) during trading hours on Thursday, reaching GBX 6,913 ($93.75). 1,993,768 shares of the company were exchanged, compared to its average volume of 1,090,000. Reckitt Benckiser Group has a 12 month low of GBX 6,299 ($85.42) and a 12 month high of GBX 8,110.43 ($109.99). The stock has a market capitalization of $48,650.00 and a PE ratio of 2,312.04.

In other news, insider Adrian Nevil Hennah purchased 2,285 shares of the stock in a transaction that occurred on Wednesday, November 8th. The shares were purchased at an average cost of GBX 6,567 ($89.06) per share, with a total value of £150,055.95 ($203,493.29). Also, insider Christopher Sinclair purchased 2,800 shares of the stock in a transaction that occurred on Wednesday, November 1st. The shares were purchased at an average cost of GBX 6,597 ($89.46) per share, for a total transaction of £184,716 ($250,496.34).

WARNING: This story was published by Daily Political and is owned by of Daily Political. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://www.dailypolitical.com/2018/01/21/jpmorgan-chase-co-reiterates-overweight-rating-for-reckitt-benckiser-group-rb.html.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.